Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2008 by National University Hospital, Singapore.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
National University Hospital, Singapore
Information provided by:
National University Hospital, Singapore
ClinicalTrials.gov Identifier:
NCT00716209
First received: July 14, 2008
Last updated: July 15, 2008
Last verified: July 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The proposal seeks to establish:
- A comprehensive compilation (database) of clinical information comprising clinical, histopathological, treatment and follow-up characteristics of past and future gastrointestinal cancer (GIC) cases in Singapore that can be shared by investigators. The characteristics will include clinical (eg age, sex, stage), histopathological (eg. grade, type), treatment (eg. treatment status, regimens) and outcome data (eg. survival, toxicity) from medical records.
- A collection (bank) of corresponding frozen and fixed tissue, blood and processed samples (enriched blood mononuclear cells, protein, RNA, DNA, tissue arrays) in Singapore that can be shared by the investigators.
- A gastrointestinal cancer co-operative group (GCCG) of clinicians and scientists researching prognostic and predictive markers in GIC, which will benefit from the multi-disciplinary knowledge, information and samples of its members.
- To characterise genetic polymorphisms related to Gastrointestinal cancer chemotherapy treatment in controls (healthy volunteers)
| Condition |
|---|
|
Gastrointestinal Cancer |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers |
Resource links provided by NLM:
Further study details as provided by National University Hospital, Singapore:
| Groups/Cohorts |
|---|
|
1
Patients with cancers of the gastrointestinal tract (eg. colorectal, gastric, pancreatic, esophageal)
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Criteria
Inclusion Criteria:
- Patients with cancers of the gastrointestinal tract (eg. colorectal, gastric, pancreatic, esophageal)
Exclusion Criteria:
- None
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00716209
Contacts
| Contact: Ross Andrew Soo, MBBS | Ross_Soo@nuh.com.sg |
Locations
| Singapore | |
| National University Hospital | Recruiting |
| Singapore, Singapore | |
| Contact: Ross Andrew Soo, MBBS 65-6772-4624 Ross_Soo@nuh.com.sg | |
| Sub-Investigator: Salto-Tellez Manuel | |
Sponsors and Collaborators
National University Hospital, Singapore
Investigators
| Principal Investigator: | Ross Andrew Soo, MBBS | National University Hospital, Singapore |
| Principal Investigator: | Alex Chang | Johns Hopkins University |
| Principal Investigator: | Chung Yip Chan | Tan Tock Seng Hospital |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00716209 History of Changes |
| Other Study ID Numbers: | NUSIRB 04-116 |
| Study First Received: | July 14, 2008 |
| Last Updated: | July 15, 2008 |
| Health Authority: | Singapore: Domain Specific Review Boards |
Additional relevant MeSH terms:
|
Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |
Neoplasms Digestive System Diseases Gastrointestinal Diseases |
ClinicalTrials.gov processed this record on May 16, 2013